SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-19-115774
Filing Date
2019-04-24
Accepted
2019-04-24 08:01:56
Documents
4
Period of Report
2019-06-06
Effectiveness Date
2019-04-24

Document Format Files

Seq Description Document Type Size
1 DEF 14A d743180ddef14a.htm DEF 14A 395603
2 GRAPHIC g743180g42e65.jpg GRAPHIC 19512
3 GRAPHIC g743180page001.jpg GRAPHIC 151946
4 GRAPHIC g743180page002.jpg GRAPHIC 134492
  Complete submission text file 0001193125-19-115774.txt   813927
Mailing Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 457-2700
Allogene Therapeutics, Inc. (Filer) CIK: 0001737287 (see all company filings)

IRS No.: 823562771 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38693 | Film No.: 19762641
SIC: 2836 Biological Products, (No Diagnostic Substances)